- Sector
- Healthcare
- Industry
- Medical Care Facilities
- IPO Date
- Sep 22, 2017
Highlights
- Market Cap
- $13.58M
- Enterprise Value
- $38.26M
- EPS (TTM)
- -$0.39
- Total Revenue (TTM)
- -$16.86M
- Gross Profit (TTM)
- -$2.95M
- EBITDA (TTM)
- -$41.99M
- Year Range
- $0.08 - $5.44
- ROA (TTM)
- -104.67%
- ROE (TTM)
- -248.22%
- Avg. Volume (1M)
- 9M
- Avg. Volume Value (1M)
- $20.42M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
SRXH Performance Chart
SRx Health Solutions Inc (SRXH) is up 520.1% since the beginning of the year. At $1 per share, SRXH is trading 74.6% below its 52-week high of $5. Investors who bought $1,000 worth of SRXH shares 5 years ago would now be looking at an investment worth $10.
Loading charts...
Compare this symbol against anything
Returns By Period
SRx Health Solutions Inc (SRXH) has returned 520.08% so far this year and 271.79% over the past 12 months.
SRx Health Solutions Inc
- 1D
- -6.76%
- 1M
- -74.00%
- 6M
- 939.70%
- YTD
- 520.08%
- 1Y
- 271.79%
- 3Y*
- -46.27%
- 5Y*
- -60.10%
- 10Y*
- —
- ALL TIME*
- -39.57%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
SRXH Monthly Returns History
Based on dividend-adjusted daily data since Sep 22, 2017, SRXH's average daily return is +5.19%, while the average monthly return is +75.17%. At this rate, an investment would double in approximately 0.1 years.
Historically, 39% of months were positive and 61% were negative. The best month was Jun 2026 with a return of +4,824.9%, while the worst month was Jul 2026 at -74.0%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.
On a daily basis, SRXH closed higher 40% of trading days. The best single day was Jun 29, 2026 with a return of +5,880.2%, while the worst single day was Mar 21, 2019 at -68.9%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -40.36% | -8.01% | 3.04% | -11.71% | -2.99% | 4,824.89% | -74.00% | 520.08% | |||||
| 2025 | -18.25% | -14.64% | 4.88% | 12.79% | -71.97% | 10.32% | -33.27% | 4.37% | -24.13% | -5.36% | 14.00% | -33.27% | -90.29% |
| 2024 | -24.08% | -11.90% | -18.92% | -11.33% | -24.25% | -3.23% | -17.95% | 0.63% | -35.09% | -12.92% | 8.79% | 18.69% | -78.76% |
| 2023 | 37.27% | -4.80% | -47.47% | 11.08% | -29.44% | -27.59% | 10.57% | -17.74% | -35.08% | 72.50% | 58.95% | -18.65% | -48.68% |
| 2022 | -29.10% | 20.52% | -7.61% | -15.29% | 20.83% | -15.71% | 8.18% | -23.53% | -56.27% | 29.43% | -33.91% | -20.82% | -83.31% |
| 2021 | 18.11% | -6.67% | 2.86% | -3.47% | -7.91% | -44.01% | -18.60% | 5.71% | 0.27% | 4.58% | -3.09% | -14.10% | -57.61% |
Benchmark Metrics
SRx Health Solutions Inc has an annualized alpha of 20411713.02%, beta of 3.45, and R2 of 0.00 versus S&P 500 Index. Calculated based on daily prices since September 22, 2017.
- This stock participated in 42.56% of S&P 500 Index downside but only -88.23% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.00 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 20,411,713.02%
- Beta
- 3.45
- R²
- 0.00
- Upside Capture
- -88.23%
- Downside Capture
- 42.56%
Return for Risk
Risk / Return Rank
SRXH ranks 82 for risk / return — above 82% of stocks peers on PortfoliosLab. Its historical combined result is among the stronger results in the peer group.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for SRx Health Solutions Inc (SRXH) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SRXH | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.37 | ||
| Sortino ratioReturn per unit of downside risk | +43.39 | ||
| Omega ratioGain probability vs. loss probability | 7.08 | 1.25 | +5.83 |
| Calmar ratioReturn relative to maximum drawdown | 3.02 | 2.00 | +1.02 |
| Martin ratioReturn relative to average drawdown | 4.19 | 8.49 | -4.30 |
Dividends
Dividend History
SRx Health Solutions Inc provided a 3.62% dividend yield over the last twelve months, with an annual payout of $0.05 per share.
| Period | TTM |
|---|---|
| Dividend | $0.05 |
Dividend yield | 3.62% |
Monthly Dividends
The table displays the monthly dividend distributions for SRx Health Solutions Inc. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.05 | $0.05 |
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the SRx Health Solutions Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the SRx Health Solutions Inc was 100.00%, occurring on Jun 23, 2026. The portfolio has not yet recovered.
The current SRx Health Solutions Inc drawdown is 99.94%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-100.00%Jun 2026 | 7y 1mo | — | 7y 2moMay 2019 - now | — |
-94.74%Jan 2019 | 8mo 4d | 1mo 18d | 9mo 22dMay 2018 - Mar 2019 | — |
-68.89%Mar 2019 | 1d | 1mo 24d | 1mo 24dMar 2019 - May 2019 | — |
-50.82%Nov 2017 | 1mo 8d | 3mo 21d | 4mo 29dSep 2017 - Feb 2018 | — |
-14.75%Mar 2018 | 11d | 1mo 14d | 1mo 25dFeb 2018 - Apr 2018 | — |
Drawdown Indicators
| SRXH | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -56.78% | -43.22% |
Max Drawdown (1Y)Largest decline over 1 year | -84.44% | -9.10% | -75.34% |
Max Drawdown (3Y)Largest decline over 3 years | -99.38% | -18.90% | -80.48% |
Max Drawdown (5Y)Largest decline over 5 years | -99.95% | -25.43% | -74.52% |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -99.94% | -1.58% | -98.36% |
Average DrawdownAverage peak-to-trough decline | -85.07% | -10.70% | -74.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 60.75% | 2.14% | +58.61% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of SRx Health Solutions Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how SRx Health Solutions Inc is priced in the market compared to other companies in the Medical Care Facilities industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for SRXH in comparison with other companies in the Medical Care Facilities industry. Currently, SRXH has a P/B value of 22.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with SRXH
Add SRx Health Solutions Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with SRXH